section name header

Y-Site Injection Compatibility (1:1 Mixture)

Ceftazidime

(Mfr: GSK)(Conc: 120 mg/mLk)

C

Valproate sodium

(Conc: 100 mg/mL)

Remarks:

Physically compatible. Under 10% ceftazidime loss. Valproate not tested

Ref:

2513